Cn Bio Innovations
CN Bio develops human organ-on-a-chip platforms for the testing and development of therapeutics for serious human diseases.
Cn Bio Innovations has raised €28M across 2 funding rounds from 2 investors, most recently a Series B round in Apr 2024. Based in Welwyn Garden City, UK; founded 2009; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€28M
€27,899,278
Funding rounds
2
Investors
2
distinct backers
Active since
2020-02
latest 2024-04
Funding by year
EUR raised per yearCn Bio Innovations — funding by year — interactive chart.
Data table
| Cn Bio Innovations — funding by year | |
|---|---|
| 2020 | €8.1M |
| 2024 | €20M |
Signals
High confidenceRaise-next likelihood33
base rate 48% for Series B
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▼ Old (17y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-04-23 | Series B | €20M | Bayland Capital,CN Innovations Holdings | View deal → |
| 2020-02-03 | Other | €8.1M | — | View deal → |